(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PG2

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

PG2

ST13

US500000086534363

Class

5

Filing

86534363

Registration

5038837

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

42

Latest update

03/21/2026

Trademark type

Combined

Nice classes

5

Filing date

02/13/2015

Registration date

09/13/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/20/2026

Last transaction

03/21/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Drawing code

5

Owner type

03

Owner location

Taipei City, TW

Examiner

LOVELACE, JAMES B

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the characters "PG2" in a stylized format with a black outline around each character of the mark.

Holders and representatives

Holders

P. C. (pessoa física)
P. C. (pessoa física)

Representatives

Joe McKinney Muncy Muncy, Geissler, Olds & Lowe, P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Traditional Chinese medicineherbal supplements; medicine for restoring blood cell counts and modulation of immunity; Traditional Chinese medicinal materialmedicinal herbs; pharmaceutical agents for the treatment of blood disorders; pharmaceutical agents for the treatment of the rare diseaseITP (Idiopathic Thrombocytopenic Purpura); medicine for human use for relieving cancer-related fatigue; nutritional supplements comprised of extracts from Astragalus membranaceus; biological preparations for preventing Chemotherapy Toxicities; chemico-pharmaceutical preparations for relieving cancer-related fatigue among cancer patients; adjuvants for enhancing white blood cellsRed blood cells and platelet counts recovery; pharmaceutical preparationsdrugs for the treatment of anemia; pharmaceutical preparations applied for Hemorrhagic Stroke and Acute Ischemic Stroke; medicated nutritional supplements; dietary supplements; nutritional supplements featuring antioxidants; nutritional supplements containing plant extracts from Astragalus membranaceus; herbal extract nutritional supplements

Publications

History of USPTO decisions and trademark events.

42 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

03/20/2026

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

03/20/2026

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

03/20/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/20/2026

E89R

TEAS SECTION 8 & 9 RECEIVED

01/06/2026

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

01/06/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/06/2026

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

01/06/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/06/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/06/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

01/06/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

01/06/2026

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

09/13/2025

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

01/11/2023

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

01/11/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/11/2023

E815

TEAS SECTION 8 & 15 RECEIVED

06/27/2022

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

09/13/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

09/13/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/28/2016

PUBO

PUBLISHED FOR OPPOSITION

06/28/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/08/2016

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

05/23/2016

ALIE

ASSIGNED TO LIE

05/17/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/16/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/14/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/13/2016

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

05/13/2016

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

01/06/2016

GNFR

FINAL REFUSAL E-MAILED

01/06/2016

CNFR

FINAL REFUSAL WRITTEN

01/06/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/09/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/09/2015

ALIE

ASSIGNED TO LIE

12/09/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/23/2015

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/21/2015

GNRT

NON-FINAL ACTION E-MAILED

05/21/2015

CNRT

NON-FINAL ACTION WRITTEN

05/21/2015

DOCK

ASSIGNED TO EXAMINER

05/20/2015

MPMK

NOTICE OF PSEUDO MARK E-MAILED

03/03/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/02/2015

NWAP

NEW APPLICATION ENTERED

02/17/2015

Continuous trademark protection

Get notified about every new filing that threatens PG2 or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.